Susan Bates, M.D.
Medical Oncology Branch and Affiliates
Head, Molecular Therapeutics Section
National Cancer Institute
9000 Rockville Pike
Building 10, Room 12N226
Bethesda, MD 20892
Dr. Susan Bates received her M.D. from the University of Arkansas School of Medicine. She completed her clinical training in internal medicine at Georgetown University in Washington, D.C., and in oncology at the NCI. Dr. Bates has held positions of increasing responsibility at the NCI, receiving tenure in 1992. Her interests range from clinical studies on drug resistance to laboratory studies on drug resistance in breast cancer and renal cell cancer. Her Molecular Therapeutics Section is dedicated to finding antineoplastic agents that, alone or in combination with other anticancer agents, improve cancer therapy. Her section is focused on new drug development.
Dr. Bates' Clinical Trial(s):
NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with lung cancer, breast cancer, and solid tumors. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.